Multicenter evaluation of Candida QuickFISH BC for identification of candida species directl'y from blood culture bottles

Journal of Clinical Microbiology

Volumn 53, Issue 5, 2015, Pages 1672-1676

  Abdelhamed, Ayman M ^a   Zhang, Sean X ^b   Watkins, Tonya ^b   Morgan, Margie A ^c   Wu, Fann ^d   Buckner, Rebecca J ^e   Fuller, Deanna D ^e   Davis, Thomas E ^e   Salimnia, Hossein ^f   Fairfax, Marilynn R ^f   Lephart, Paul R ^f   Poulter, Melinda D ^g   Regi, Sarah B ^g   Jacobs, Michael R ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d Department of Medicine   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD CULTURE; BLOOD CULTURE BOTTLE; CANDIDA; CANDIDA ALBICANS; CANDIDA AURIS; CANDIDA DUBLINIENSIS; CANDIDA FAMATA; CANDIDA GLABRATA; CANDIDA METAPSILOSIS; CANDIDA ORTHOPSILOSIS; CANDIDA PARAPSILOSIS; CANDIDA QUICKFISH BC; CANDIDA RUGOSA; CANDIDA TROPICALIS; CANDIDA ZEYLANOIDES; CLAVISPORA LUSITANIAE; CRYPTOCOCCUS NEOFORMANS; EXOPHILIA DERMATITIDIS; FLUORESCENCE ANALYSIS; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; KLUYVEROMYCES MARXIANUS; LABORATORY DEVICE; MALASSEZIA PACHYDERMATIS; MEASUREMENT ACCURACY; MEYEROZYMA GUILLIERMONDII; NONHUMAN; NUCLEIC ACID ANALYSIS; NUCLEIC ACID HYBRIDIZATION; PICHIA KUDRIAVZEVII; PRIORITY JOURNAL; RHODOTORULA; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY; BLOOD; CANDIDEMIA; CLASSIFICATION; CLINICAL TRIAL; EVALUATION STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOLECULAR DIAGNOSIS; MULTICENTER STUDY; PROCEDURES;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS;

BLOOD; CANDIDA; CANDIDEMIA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICROBIOLOGICAL TECHNIQUES; MOLECULAR DIAGNOSTIC TECHNIQUES; SENSITIVITY AND SPECIFICITY;

EID: 84928007428     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00549-15     Document Type: Article

References (45)

1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. 2004. Nosocomial bloodstream infections in U.S. hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309-317. http://dx.doi.org/10.1086/421946.
2. Perlroth J, Choi B, Spellberg B. 2007. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol 45:321-346. http://dx.doi.org/10.1080/13693780701218689.
3. Pfaller MA, Diekema DJ. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20:133-163. http://dx.doi.org/10.1128/CMR.00029-06.
4. Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D. 2003. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37:1172-1177. http://dx .doi.org/10.1086/378745.
5. Bassetti M, Righi E, Ansaldi F, Merelli M, Cecilia T, De Pascale G, Diaz-Martin A, Luzzati R, Rosin C, Lagunes L, Trecarichi EM, Sanguinetti M, Posteraro B, Garnacho-Montero J, Sartor A, Rello J, Rocca GD, Antonelli M, Tumbarello M. 2014. A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med 40:839-845. http://dx.doi.org/10.1007/s00134-014-3310-z.
6. Bassetti M, Merelli M, Righi E, Diaz-Martin A, Rosello EM, Luzzati R, Parra A, Trecarichi EM, Sanguinetti M, Posteraro B, Garnacho-Montero J, Sartor A, Rello J, Tumbarello M. 2013. Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microbiol 51:4167-4172. http://dx.doi.org/10.1128/JCM.01998-13.
7. Prasad PA, Fisher BT, Coffin SE, Walsh TJ, McGowan KL, Gross R, Zaoutis TE. 2013. Pediatric risk factors for candidemia secondary to Candida glabrata and Candida krusei species. J Pediatr Infect Dis Soc 2:263-266. http://dx.doi.org/10.1093/jpids/pis093.
8. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. 2005. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 41:1232-1239. http://dx.doi.org/10.1086/496922.
9. Maccallum DM. 2012. Hosting infection: experimental models to assay Candida virulence. Int J Microbiol 2012:363764. http://dx.doi.org/10 .1155/2012/363764.
10. Miceli MH, Diaz JA, Lee SA. 2011. Emerging opportunistic yeast infections. Lancet Infect Dis 11:142-151. http://dx.doi.org/10.1016/S1473-3099(10)70218-8.
11. Papon N, Courdavault V, Clastre M, Bennett RJ. 2013. Emerging and emerged pathogenic Candida species: beyond the Candida albicans paradigm. PLoS Pathog 9:e1003550. http://dx.doi.org/10.1371/journal.ppat .1003550.
12. Murray PR, Masur H. 2012. Current approaches to the diagnosis of bacterial and fungal bloodstream infections in the intensive care unit. Crit Care Med 40:3277-3282. http://dx.doi.org/10.1097/CCM.0b013e318270e771.
13. Brandt ME, Warnock DW. 2011. Taxonomy and classification of fungi., p 1749-1755. In Versalovic J, Carroll KC, FunkeG(ed), Manual of clinical microbiology, vol 2, 10th ed. ASM Press, Washington, DC.
14. Fernandez J, Erstad BL, Petty W, Nix DE. 2009. Time to positive culture and identification for Candida blood stream infections. Diagn Microbiol Infect Dis 64:402-407. http://dx.doi.org/10.1016/j.diagmicrobio.2009.04 .002.
15. Stone NR, Gorton RL, Barker K, Ramnarain P, Kibbler CC. 2013. Evaluation of PNA-FISH yeast traffic light for rapid identification of yeast directly from positive blood cultures and assessment of clinical impact. J Clin Microbiol 51:1301-1302. http://dx.doi.org/10.1128/JCM.00028-13.
16. Hall L, Le Febre KM, Deml SM, Wohlfiel SL, Wengenack NL. 2012. Evaluation of the Yeast Traffic LightPNAFISH probes for identification of Candida species from positive blood cultures. J Clin Microbiol 50:1446-1448. http://dx.doi.org/10.1128/JCM.06148-11.
17. Neely LA, Audeh M, Phung NA, Min M, Suchocki A, Plourde D, Blanco M, Demas V, Skewis LR, Anagnostou T, Coleman JJ, Wellman P, Mylonakis E, Lowery TJ. 2013. T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood. Sci Transl Med 5:182ra154. http://dx.doi.org/10.1126/scitranslmed.3005377.
18. Beyda ND, Alam MJ, Garey KW. 2013. Comparison of the T2Dx instrument with T2Candida assay and automated blood culture in the detection of Candida species using seeded blood samples. Diagn Microbiol Infect Dis 77:324-326. http://dx.doi.org/10.1016/j.diagmicrobio.2013.07.007.
19. Foongladda S, Mongkol N, Petlum P, Chayakulkeeree M. 2014. Multiprobe real-time PCR identification of four common Candida species in blood culture broth. Mycopathologia 177:251-261. http://dx.doi.org/10 .1007/s11046-014-9743-7.
20. Xafranski H, Melo AS, Machado AM, Briones MR, Colombo AL. 2013. A quick and low-cost PCR-based assay for Candida spp. identification in positive blood culture bottles. BMC Infect Dis 13:467. http://dx.doi.org/10.1186/1471-2334-13-467.
21. Lau A, Halliday C, Chen SC, Playford EG, Stanley K, Sorrell TC. 2010. Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR. J Clin Microbiol 48:811-816. http://dx.doi.org/10.1128/JCM.01650-09.
22. Mandviwala T, Shinde R, Kalra A, Sobel JD, Akins RA. 2010. Highthroughput identification and quantification of Candida species using high resolution derivative melt analysis of panfungal amplicons. J Mol Diagn 12:91-101. http://dx.doi.org/10.2353/jmoldx.2010.090085.
23. Laffler TG, Cummins LL, McClain CM, Quinn CD, Toro MA, Carolan HE, Toleno DM, Rounds MA, Eshoo MW, Stratton CW, Sampath R, Blyn LB, Ecker DJ, Tang YW. 2013. Enhanced diagnostic yields of bacteremia and candidemia in blood specimens by PCR-electrospray ionization mass spectrometry. J Clin Microbiol 51:3535-3541. http://dx.doi.org/10.1128/JCM.00876-13.
24. De Luca Ferrari M, Ribeiro Resende M, Sakai K, Muraosa Y, Lyra L, Gonoi T, Mikami Y, Tominaga K, Kamei K, Zaninelli Schreiber A, Trabasso P, Moretti ML. 2013. Visual analysis of DNA microarray data for accurate molecular identification of non-albicans Candida isolates from patients with candidemia episodes. J Clin Microbiol 51:3826-3829. http://dx.doi.org/10.1128/JCM.01050-13.
25. Altun O, Almuhayawi M, Ullberg M, Ozenci V. 2013. Clinical evaluation of the FilmArray blood culture identification panel in identification of bacteria and yeasts from positive blood culture bottles. J Clin Microbiol 51:4130-4136. http://dx.doi.org/10.1128/JCM.01835-13.
26. Madhavan P, Jamal F, Chong PP, Ng KP. 2011. Identification of local clinical Candida isolates using CHROMagar Candida as a primary identification method for various Candida species. Trop Biomed 28:269-274.
27. Xavier PC, Chang MR, Paula CR, Matsumoto FE, Asensi MD, Matos Mde F, Andreotti R. 2013. Molecular characterization of Candida spp. isolates from patients with bloodstream infections. Rev Soc Bras Med Trop 46:786-787. http://dx.doi.org/10.1590/0037-8682-1718-2013.
28. Spanu T, Posteraro B, Fiori B, D'Inzeo T, Campoli S, Ruggeri A, Tumbarello M, Canu G, Trecarichi EM, Parisi G, Tronci M, Sanguinetti M, Fadda G. 2012. Direct maldi-tof mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories. J Clin Microbiol 50:176-179. http://dx.doi.org/10.1128/JCM .05742-11.
29. Calderaro A, Martinelli M, Motta F, Larini S, Arcangeletti MC, Medici MC, Chezzi C, De Conto F. 2013. Comparison of peptide nucleic acid fluorescence in situ hybridization assays with culture-based matrixassisted laser desorption/ionization-time of flight mass spectrometry for the identification of bacteria and yeasts from blood cultures and cerebrospinal fluid cultures. Clin Microbiol Infect 20:O468-O475. http://dx.doi .org/10.1111/1469-0691.12490.
30. Yan Y, He Y, Maier T, Quinn C, Shi G, Li H, Stratton CW, Kostrzewa M, Tang YW. 2011. Improved identification of yeast species directly from positive blood culture media by combining SepsiTyper specimen processing and Microflex analysis with the matrix-assisted laser desorption ionization BioTyper system. J Clin Microbiol 49:2528-2532. http://dx.doi .org/10.1128/JCM.00339-11.
31. Gorton RL, Ramnarain P, Barker K, Stone N, Rattenbury S, McHugh TD, Kibbler CC. 2014. Comparative analysis of Gram's stain, PNA-FISH and Sepsityper with MALDI-TOF MS for the identification of yeast direct from positive blood cultures. Mycoses 57:592-5601. http://dx.doi.org/10 .1111/myc.12205.
32. Rigby S, Procop GW, Haase G, Wilson D, Hall G, Kurtzman C, Oliveira K, Von Oy S, Hyldig-Nielsen JJ, Coull J, Stender H. 2002. Fluorescence in situ hybridization with peptide nucleic acid probes for rapid identification of Candida albicans directly from blood culture bottles. J Clin Microbiol 40:2182-2186. http://dx.doi.org/10.1128/JCM.40.6.2182-2186.2002.
33. Cobos-Trigueros N, Kaasch AJ, Soriano A, Torres JL, Vergara A, Morata L, Zboromyrska Y, De La Calle C, Alejo I, Hernandez C, Cardozo C, Marco F, Del Rio A, Almela M, Mensa J, Martinez JA. 2014. Time to positivity and detection of growth in anaerobic blood culture vials predict the presence of Candida glabrata in candidemia: a two-center European cohort study. J Clin Microbiol 52:3082-3084. http://dx.doi.org/10 .1128/JCM.01198-14.
34. Tavanti A, Davidson AD, Gow NA, Maiden MC, Odds FC. 2005. Candida orthopsilosis and Candida metapsilosis spp. Nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol 43:284-292. http://dx .doi.org/10.1128/JCM.43.1.284-292.2005.
35. Miranda-Zapico I, Eraso E, Hernandez-Almaraz JL, Lopez-Soria LM, Carrillo-Munoz AJ, Hernandez-Molina JM, Quindos G. 2011. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital. J Antimicrob Chemother 66:2315-2322. http://dx.doi.org/10.1093/jac/dkr298.
36. Goncalves SS, Amorim CS, Nucci M, Padovan AC, Briones MR, Melo AS, Colombo AL. 2010. Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil. Clin Microbiol Infect 16:885-887. http://dx.doi.org/10.1111/j.1469-0691.2009.03020.x.
37. Tavanti A, Hensgens LA, Ghelardi E, Campa M, Senesi S. 2007. Genotyping of Candida orthopsilosis clinical isolates by amplification fragment length polymorphism reveals genetic diversity among independent isolates and strain maintenance within patients. J Clin Microbiol 45:1455-1462. http://dx.doi.org/10.1128/JCM.00243-07.
38. Garcia-Effron G, Canton E, Peman J, Dilger A, Roma E, Perlin DS. 2011. Assessment of two new molecular methods for identification of Candida parapsilosis sensu lato species. J Clin Microbiol 49:3257-3261. http://dx.doi.org/10.1128/JCM.00508-11.
39. Aitken SL, Beyda ND, Shah DN, Palmer HR, Lasco TM, Koo H, Garey KW. 2014. Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics. Ann Pharmacother 48:683-690. http://dx.doi.org/10 .1177/1060028014529928.
40. Zilberberg MD, Kollef MH, Arnold H, Labelle A, Micek ST, Kothari S, Shorr AF. 2010. Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study. BMC Infect Dis 10:150. http://dx.doi.org/10.1186/1471-2334-10-150.
41. Vazquez J, Reboli AC, Pappas PG, Patterson TF, Reinhardt J, Chin-Hong P, Tobin E, Kett DH, Biswas P, Swanson R. 2014. Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial. BMC Infect Dis 14:97. http://dx .doi.org/10.1186/1471-2334-14-97.
42. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Jr, Calandra TF, Edwards JE, Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD. 2009. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48:503-535. http://dx.doi.org/10.1086/596757.
43. Jensen TG, Gahrn-Hansen B, Arendrup M, Bruun B. 2004. Fusarium fungaemia in immunocompromised patients. Clin Microbiol Infect 10: 499-501. http://dx.doi.org/10.1111/j.1469-0691.2004.00859.x.
44. Pietrucha-Dilanchian P, Lewis RE, Ahmad H, Lechin AE. 2001. Candida lusitaniae catheter-related sepsis. Ann Pharmacother 35:1570-1574. http://dx.doi.org/10.1345/aph.1A077.
45. Simarro E, Marin F, Morales A, Sanz E, Perez J, Ruiz J. 2001. Fungemia due to Scedosporium prolificans: a description of two cases with fatal outcome. Clin Microbiol Infect 7:645-647. http://dx.doi.org/10.1046/j.1198-743x.2001.00317.x.